PCG
ANIP icon

Private Capital Group’s ANI Pharmaceuticals ANIP Stock Holding History

Private Capital Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-766
Closed -$47K – 1969
2019
Q4 		$47K Buy
766
+92
+14% +$6.09K 0.01% 769
2019
Q3 		$49K Sell
674
-149
-18% -$11.1K 0.01% 786
2019
Q2 		$55K Buy
823
+87
+12% +$6.19K 0.01% 619
2019
Q1 		$52K Hold
736
– – 0.01% 750
2018
Q4 		$33K Sell
736
-87
-11% -$4.56K 0.01% 855
2018
Q3 		$46K Hold
823
– – 0.01% 752
2018
Q2 		$54K Hold
823
– – 0.01% 658
2018
Q1 		$48K Buy
823
+194
+31% +$12.3K 0.01% 696
2017
Q4 		$56 Buy
+629
New +$39.1K 0.01% 646

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return